Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Riether

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 24, 2008
Calcineurin inhibition in splenocytes induced by pavlovian conditioningGustavo Pacheco-López, Carsten Riether, Raphael Doenlen, et al.
Science Translational Medicine|July 31, 2015
Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signalingCarsten Riether, Christian M Schürch, Christoph Flury, et al.
Science Signaling|August 29, 2023
IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathwaysPascal Naef, Ramin Radpour, Carla A Jaeger-Ruckstuhl, et al.
Iscience|May 19, 2025
IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and agingPascal Naef, Carla A Jaeger-Ruckstuhl, Noah Schnüriger, et al.
The International Journal of Neuropsychopharmacology|January 6, 2012
Neurobehavioural activation during peripheral immunosuppressionGustavo Pacheco-López, Raphael Doenlen, Ute Krügel, et al.
The Journal of Experimental Medicine|December 30, 2016
CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemiaCarsten Riether, Christian M Schürch, Elias D Bührer, et al.
Blood|May 13, 2017
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignanciesMohamad F Al Sayed, Carla A Ruckstuhl, Tamara Hilmenyuk, et al.
Brain, Behavior, and Immunity|June 3, 2009
Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's diseaseHarald Engler, Raphael Doenlen, Carsten Riether, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 7, 2022
The CD70-CD27 axis in oncology: the new kids on the blockTal Flieswasser, Astrid Van den Eynde, Jonas Van Audenaerde, et al.
Oncoimmunology|January 4, 2018
T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's LymphomaTamara Hilmenyuk, Carla A Ruckstuhl, Michael Hayoz, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 24, 2008
Calcineurin inhibition in splenocytes induced by pavlovian conditioningGustavo Pacheco-López, Carsten Riether, Raphael Doenlen, et al.
Science Translational Medicine|July 31, 2015
Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signalingCarsten Riether, Christian M Schürch, Christoph Flury, et al.
Science Signaling|August 29, 2023
IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathwaysPascal Naef, Ramin Radpour, Carla A Jaeger-Ruckstuhl, et al.
Iscience|May 19, 2025
IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and agingPascal Naef, Carla A Jaeger-Ruckstuhl, Noah Schnüriger, et al.
The International Journal of Neuropsychopharmacology|January 6, 2012
Neurobehavioural activation during peripheral immunosuppressionGustavo Pacheco-López, Raphael Doenlen, Ute Krügel, et al.
The Journal of Experimental Medicine|December 30, 2016
CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemiaCarsten Riether, Christian M Schürch, Elias D Bührer, et al.
Blood|May 13, 2017
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignanciesMohamad F Al Sayed, Carla A Ruckstuhl, Tamara Hilmenyuk, et al.
Brain, Behavior, and Immunity|June 3, 2009
Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's diseaseHarald Engler, Raphael Doenlen, Carsten Riether, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 7, 2022
The CD70-CD27 axis in oncology: the new kids on the blockTal Flieswasser, Astrid Van den Eynde, Jonas Van Audenaerde, et al.
Oncoimmunology|January 4, 2018
T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's LymphomaTamara Hilmenyuk, Carla A Ruckstuhl, Michael Hayoz, et al.
Pageof 8